Literature DB >> 35328917

Effectiveness of Telematic Behavioral Techniques to Manage Anxiety, Stress and Depressive Symptoms in Patients with Chronic Musculoskeletal Pain: A Systematic Review and Meta-Analysis.

Ferran Cuenca-Martínez1, Luis Suso-Martí1, Aida Herranz-Gómez1, Clovis Varangot-Reille1, Joaquín Calatayud1, Mario Romero-Palau2, María Blanco-Díaz3, Cristina Salar-Andreu4, Jose Casaña1.   

Abstract

Anxiety, depressive symptoms and stress have a significant influence on chronic musculoskeletal pain. Behavioral modification techniques have proven to be effective to manage these variables; however, the COVID-19 pandemic has highlighted the need for an alternative to face-to-face treatment. We conducted a search of PubMed, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), Web of Science, APA PsychInfo, and Psychological and Behavioural Collections. The aim was to assess the effectiveness of telematic behavioral modification techniques (e-BMT) on psychological variables in patients with chronic musculoskeletal pain through a systematic review with meta-analysis. We used a conventional pairwise meta-analysis and a random-effects model. We calculated the standardized mean difference (SMD) with the corresponding 95% confidence interval (CI). Forty-one randomized controlled trials were included, with a total of 5018 participants. We found a statistically significant small effect size in favor of e-BMT in depressive symptoms (n = 3531; SMD = -0.35; 95% CI -0.46, -0.24) and anxiety (n = 2578; SMD = -0.32; 95% CI -0.42, -0.21) with low to moderate strength of evidence. However, there was no statistically significant effect on stress symptoms with moderate strength of evidence. In conclusion, e-BMT is an effective option for the management of anxiety and depressive symptoms in patients with chronic musculoskeletal pain. However, it does not seem effective to improve stress symptoms.

Entities:  

Keywords:  anxiety; behavior; depression; stress; telerehabilitation

Mesh:

Year:  2022        PMID: 35328917      PMCID: PMC8951553          DOI: 10.3390/ijerph19063231

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


1. Introduction

The COVID-19 pandemic has shaken our lives and jeopardized the treatment of countless patients with chronic pain [1,2]. Chronic pain patients have shown a significant increase in their perceived pain in comparison with the pre-pandemic period [3], as well as an increase in depressive symptoms, anxiety, loneliness, tiredness and catastrophizing [3]. Nearly half of a sample of 2423 chronic pain patients had moderate to severe psychological distress [4]. The worsening of mental health in patients with chronic pain is not without consequences; these variables have been linked to higher pain catastrophizing, pain-related fear and avoidance, and a higher risk of misuse of opioids [5,6]. These patients need follow-up, a close relationship with health professionals and appropriate treatment, but social distancing prevents them from doing so [1]. Chronic pain patients had higher self-isolation than participants without pain during the pandemic [3]. Because it does not require being physically present, telerehabilitation, or the therapeutic use of technological devices, has been recommended for chronic pain management worldwide [2]. Over the last few decades, behavioral modification techniques (BMT) have showed to be effective in the management of psychological variables in chronic pain patients [7,8]. However, it is not clear if telematic BMT (e-BMT) is also effective to improve psychological variables and if it is as effective as in-person BMT. Some previous systematic reviews have assessed the effect of telerehabilitation based on BMT on variables such as pain intensity, disability, disease impact, physical function, pain-related fear of movement, and psychological distress [9,10,11,12], showing promising results. The primary aim of this systematic review with meta-analysis was to evaluate the effectiveness of e-BMT compared with usual care/waiting list or in-person BMT in psychological variables. Secondly, we aimed to sub-analyze the results by intervention parameters and diagnostic conditions. The main reason for the secondary aim was because the “BMT” label includes a large range of interventions and so we can isolate effects by intervention or by clinical entities.

2. Materials and Methods

This systematic review and meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 2020 statement [13]. This systematic review was registered prospectively in an international database (PROSPERO), where it can be accessed (CRD42021278086).

2.1. Search Strategy

The search strategy of this systematic review is the same as another systematic review from our research group on this topic, which is currently under review. The search for studies was performed using Medline (PubMed), the Cumulative Index to Nursing and Allied Health Literature (CINAHL), Web of Science, APA PsychInfo, and Psychological and Behavioural Collections, from inception to (30) August 2021. In addition, we manually checked the references of the studies included in the review and checked the studies included in systematic reviews related to this topic. The search was also adapted and performed in Google Scholar due to its capacity to search for relevant articles and grey literature [14]. No restrictions were applied to any specific language. The different search strategies used are detailed in Appendix A.1. Two independent reviewers (CVR and FCM) conducted the search using the same methodology, and the differences were resolved by consensus moderated by a third reviewer (JCG). We used Rayyan software to organize studies, assess studies for eligibility and remove duplicates [15].

2.2. Study Eligibility Criteria

The selection criteria used in this systematic review and meta-analysis were based a Population, Intervention, Control, Outcomes, and Study design framework (PICOS). We included randomized controlled trials that have applied e-BMT through a technology device (Website, online, telephone or mobile application). The intervention could be applied alone or embedded with another treatment, only if the control group contains only the additional treatment. Control group could be usual care, waiting list, no intervention, or in-person equivalent BMT. The participants selected for the studies were patients older than 18 years with any kind of chronic musculoskeletal disorder. The participants’ gender was irrelevant. We excluded patients with musculoskeletal pain due to oncologic or traumatic process. The measures used to assess the results were depressive symptoms, anxiety, and stress. Time of measurement was restrained to post-treatment results.

2.3. Selection Process and Data Extraction

The two phases of studies selection (title/abstract screening and full-text evaluation) were realized by two independent reviewers (CVR and FCM). First, they assessed the relevance of the studies regarding the study questions and aims, based on information from the title, abstract, and keywords of each study. If there was no consensus or the abstracts did not contain sufficient information, the full text was reviewed. In the second phase of the analysis, the full text was used to assess whether the studies met all the inclusion criteria. Differences between the two independent reviewers were resolved by a consensus process moderated by a third reviewer (JCG). Data described in the results were extracted by means of a structured protocol that ensured that the most relevant information was obtained from each study [16].

2.4. Risk of Bias and Methodological Quality Assessment

The Risk Of Bias 2 (RoB 2) tool was used to assess randomized trials [17]. It covers a total of 5 domains: (1) Bias arising from the randomization process, (2) Bias due to deviations from the intended interventions, (3) Bias due to missing outcome data, (4) Bias in measurement of the outcome, (5) Bias in selection of the reported result. The study will be categorized as having (a) low risk of bias if all domains shown low risk of bias, (b) some concerns if one domain is rated with some concerns without any with high risk of bias, and (c) high risk of bias, if one domain is rated as having high risk of bias or multiple with some concerns. The studies’ methodological quality was assessed using the PEDro scale [18], which assesses the internal and external validity of a study and consists of 11 criteria. The methodological criteria were scored as follows: yes (1 point), no (0 points), or do not know (0 points). The PEDro score for each selected study provided an indicator of the methodological quality (9–10 = excellent; 6–8 = good; 4–5 = fair; 3–0 = poor) [19]. We used the data obtained from the PEDro scale to map the results of the quantitative analyses. Two independent reviewers (LSM and FCM) examined the quality and the risk of bias of all the selected studies using the same methodology. Disagreements between the reviewers were resolved by consensus with a third reviewer (JCG). Concordance between the results (inter-rater reliability) was measured using Cohen’s kappa coefficient (κ) as follows: (1) κ > 0.7 indicated a high level of agreement between assessors; (2) κ = 0.5–0.7 indicated a moderate level of agreement; and (3) κ < 0.5 indicated a low level of agreement [20].

2.5. Quality of Evidence

The quality of evidence analysis was based on classifying the results into levels of evidence according to the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework, which is based on 5 domains: study design, imprecision, indirectness, inconsistency, and publication bias [21]. The assessment of the 5 domains was conducted according to GRADE criteria [22,23]. Evidence was categorized into the following 4 levels accordingly: (a) High quality. Further research is very unlikely to change our confidence in the effect estimate. All 5 domains are also met. (b) Moderate quality. Further research is likely to have an important impact on our confidence in the effect estimate and might change the effect estimate. One of the 5 domains is not met. (c) Low quality. Further research is very likely to have a significant impact on our confidence in the effect estimate and is likely to change the estimate. Two of the 5 domains are not met. (d) Very low quality. Any effect estimates highly uncertain. Three of the 5 domains are not met [22,23]. For the risk of bias domain, the recommendations were downgraded one level in the event there was an uncertain or high risk of bias and serious limitations in the effect estimate (more that 25% of the participants were from studies with high risk of bias, as measured by the RoB 2 scale). In terms of inconsistency, the recommendations were downgraded one level when the point estimates varied widely among studies, the confidence intervals showed minimal overlap or when the I2 was substantial or large (greater than 50%). For the indirectness domain, recommendations were downgraded when severe differences in interventions, study populations or outcomes were found. (The recommendations were downgraded in the absence of direct comparisons between the interventions of interest or when there are no key outcomes, and the recommendation is based only on intermediate outcomes or if more than 50% of the participants were outside the target group.) For the imprecision domain, the recommendations were downgraded one level if there were fewer than 300 participants for the continuous data. Finally, the recommendations were downgraded due to strong influence of publication bias if the results changed significantly after adjusting for publication bias.

2.6. Data Synthesis

The statistical analysis was conducted using RStudio software version 1.4.1717, which is based on R software version 4.1.1 [24,25]. To compare the outcomes reported by the studies, we calculated the standardized mean difference (SMD), as Hedge’s g, over time and the corresponding 95% confidence interval (CI) for the continuous variables. It was interpreted as described by Hopkins et al. [26]. If necessary, CI and standard error (SE) were converted into standard deviation (SD) [27]. The estimated SMDs were interpreted as described by Hopkins et al. [26]; that is, we considered an SMD of 4.0 to represent an extremely large clinical effect, 2.0–4.0 represented a very large effect, 1.2–2.0 represented a large effect, 0.6–1.2 represented a moderate effect, 0.2–0.6 represented a small effect, and 0.0–0.2 represented a trivial effect. We used the same inclusion criteria for the systematic review and the meta-analysis and included 3 additional criteria: (1) In the results, there was detailed information regarding the comparative statistical data of the exposure factors, therapeutic interventions, and treatment responses; (2) the intervention was compared with a similar control group; and (3) data on the analyzed variables were represented in at least 3 studies. As we pooled different treatments, we could not assume that there was a unique true effect. So, we anticipated between-study heterogeneity and used a random-effects model to pool effect sizes. In order the calculate the heterogeneity variance τ2, we used the Restricted Maximum Likelihood Estimator as recommended for continuous outcomes [28,29]. To calculate the confidence interval around the pooled effect, we used Knapp–Hartung adjustments [30,31]. We estimated the degree of heterogeneity among the studies using Cochran’s Q statistic test (a p-value < 0.05 was considered significant), the inconsistency index (I2) and the prediction interval (PI) based on the between-study variance τ2 [26]. Cochran’s Q test allows us to assess the presence of between-study heterogeneity [32]. Despite its common use to assess heterogeneity, the I2 index only represents the percentage of variability in the effect sizes not caused by a sampling error [33]. Therefore, as recommended, we additionally report PIs. The PIs are an equivalent to standard deviation and represent a range within which the effects of future studies are expected to fall based on current data [33,34]. To detect the presence of outliers that could potentially influence the estimated pooled effect and assess the robustness of our results, we applied an influence analysis based on the leave-one-out method [35]. If the study’s results had an important influence on the pooled effect, we conducted a sensitivity analysis removing it or them. We additionally ran a drapery plot, which is based on p-value functions and gives us the p-value curve for the pooled estimate for all possible alpha levels [36]. To detect publication bias, we performed a visual evaluation of the Doi plot and the funnel plot [37], seeking asymmetry. We also performed a quantitative measure of the Luis Furuya Kanamori (LFK) index, which has been shown to be more sensitive than the Egger test in detecting publication bias in a meta-analysis of a low number of studies [38]. An LFK index within ±1 represents no asymmetry, exceeding ±1 but within ±2 represents minor asymmetry, and exceeding ±2 involves major asymmetry. If there was significant asymmetry, we applied a small-study effect method to correct for publication bias using the Duval and Tweedie trim and fill method [39]. For the qualitative analysis, we reported the between-group mean difference (MD) with the 95% CI for the outcomes of interest. If it was not reported by the authors, we calculated it [40].

3. Results

3.1. Descriptions of the Studies

From the 749 studies initially detected, a total of 41 RCTs were included [41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81]. The PRISMA 2020 flow chart is detailed in Appendix A.2. We included 5018 participants with a mean age ranging from 33.7 to 65.8 years. The patients were mostly women (N = 3631, 72.4%) diagnosed with chronic back pain [47,52,72,79,80], chronic low back pain [41,55], unspecific chronic pain [43,51,53,56,59,67,68,69,70,71,73,74,75,76,81], fibromyalgia [42,46,48,49,58,63,66], headache [44,60,61,78], rheumatic disorders [45,57,62,64], or others [50,54,65]. Details of the participant’s characteristics and studies are shown in Appendix A.3. The studies compared online cognitive-behavioral therapy [42,43,45,46,47,54,55,59,63,70,72,79,80,81], acceptance and commitment therapy [56,58,70,71,73,76], self-management [52,59,62,66,67,68,69,77], mindfulness therapy [61,65,70,72,76], or other e-BMT [41,44,48,49,50,53,57,60,64,74,75,78], against most frequently waiting list [43,44,46,48,51,54,56,57,60,62,64,68,71,72,74,75,77,79,80,81], usual care [42,45,47,49,52,55,58,59,61,63,66,67,69,70,73,78], or in-person intervention [50,63,76]. The intervention duration ranged between a single day [65] and 6 months [41,50,62,66,78]. The details of the interventions are described in Appendix A.4 using the Behavior Change Technique Taxonomy (v1) [82].

3.2. Methodological Quality and Risk of Bias

According to the PEDro scale, 30 were evaluated as having good [41,42,43,44,45,46,47,48,49,50,51,55,56,58,59,62,63,64,65,66,68,70,71,72,73,75,76,77,78,80] and 11 as having fair methodological quality [52,53,54,57,60,61,67,69,74,79,81] (Appendix A.5). The inter-rater reliability of the methodological quality assessment between assessors was high (κ = 0.823). According to the Rob 2 scale, all the studies have a high risk of bias (100%) (Figure 1 and Appendix A.6). The inter-rater reliability of the risk of bias assessment between assessors was high (κ = 0.884).
Figure 1

Risk of bias graph according to the Risk of Bias 2 tool.

3.3. Qualitative Synthesis

Four studies compared e-BMT with in-person BMT. They applied CBT [47,63], ACT [76] or person-centered intervention [50]. Two found non-statistically significant differences between groups for depressive symptoms (n = 253; MD = 0.24, 95% CI −2.32 to 2.80 [47] and MD = −0.51, 95% CI −2.42 to 1.40 [76]); however, Vallejo et al. found statistically significant between-group differences post-treatment in favor of e-BMT (n = 40; MD = −5.06, 95% CI −7.39 to −2.73) [63]. One found a non-statistically significant difference between groups for anxiety (n = 128; MD = −4.20, 95% CI −10.58 to 2.17) [76] and one found a non-statistically significant difference between groups for stress (n = 109; MD = −2.76, 95% CI −5.94 to 1.28) [50].

3.4. Quantitative Synthesis

3.4.1. Depressive Symptoms

According to the influence analyses, we conducted a sensitivity analysis without Dear et al. [43]. We found a statistically significant small effect size (32 RCTs; n = 3531; SMD = −0.35; 95% CI −0.46, −0.24) of e-BMT on depressive symptoms compared with usual care or waiting list, with significant heterogeneity (Q = 74.06 (p < 0.01); I2 = 57% (36%, 71%); PI −0.82, 0.12) and a low strength of evidence (Figure 2). Since PI crosses zero, we cannot be confident that future studies will not find contradictory results; however, the results appear to be robust to different p-value functions. With respect to the presence of publication bias, the funnel and Doi plots show an asymmetrical pattern, demonstrating minor asymmetry (LFK index = −1.62). When the sensitivity analysis is adjusted for publication bias, there is still a small significant effect. Statistical analyses are detailed in Appendix A.7. Subgroup analyses are detailed in Table 1a.
Figure 2

Sensitivity analysis of the depressive symptoms variable for telematic behavioral modification techniques against usual care or waiting list. Negative results favor the intervention group. The small boxes with the squares represent the point estimate of the effect size and sample size. The lines on either side of the box represent a 95% confidence interval (CI). e-BMT: Telematic Behavioral Modification Techniques.

Table 1

Subgroup analysis.

Outcomes Sub = AnalysisN StudiesSMDLower Limit 95%CIUpper Limit 95% CIQI2
(a) Depressive Symptoms—Treatment
ACT5−0.39−0.71−0.076.3837%
CBT11−0.46−0.73−0.1929.2166%
Positive Psychology2−0.61−1.770.550.450%
Self-management8−0.12−0.260.036.300%
Other types of treatment7−0.30−0.58−0.0311.1946%
Depressive Symptoms—Chronic Musculoskeletal disorder
Back pain5−0.24−0.530.055.5828%
Fibromyalgia7−0.66−1.01−0.3114.1658%
Headache3−0.14−0.19−0.090.020%
Rheumatic disorders4−0.28−0.680.125.8549%
Unspecified chronic pain 13−0.33−0.51−0.1536.6165%
Depressive Symptoms—Added to usual care treatment? (Y/N)
Only e-BMT24−0.34−0.46−0.2252.2654%
e-BMT added to usual care 8−0.41−0.80−0.0321.7968%
Depressive Symptoms—Intervention duration
Between 1 and 6 weeks6−0.02−0.170.122.440%
Between 7 and 11 weeks18−0.46−0.61−0.3136.7051%
12 weeks and more8−0.26−0.50−0.0312.5444%
Depressive Symptoms—Methodological Quality according to the PEDro scale
Fair methodological quality7−0.18−0.430.0710.8645%
Good methodological quality25−0.39−0.52−0.2654.0854%
(b) Anxiety—Treatment
ACT3−0.31−0.930.314.7558%
CBT10−0.31−0.50−0.1214.7139%
Positive psychology2−0.37-1.280.530.280%
Self-Management3−0.20−0.700.302.3415%
Other types of treatment4−0.41−0.970.148.4364%
Anxiety—Chronic Musculoskeletal disorder
Unspecific back pain3−0.09−0.750.582.4318%
Fibromyalgia5−0.45−0.85−0.058.1751%
Headache1−0.14−0.850.18N/AN/A
Rheumatic disorders2−0.35-2.471.771.6740%
Unspecified chronic pain10−0.33−0.47−0.1916.1238%
Anxiety—Intervention duration
1 to 6 weeks20.02-1.962.011.4129%
7 to 11 weeks13−0.41−0.50−0.3110.340%
12 weeks and more6−0.25−0.560.069.1345%
Anxiety—Added to usual care treatment? (Y/N)
Only e-BMT17−0.34−0.45−0.2226.8537%
e-BMT added to usual care 4−0.19−0.590.224.9539%
Anxiety—Methodological Quality according to the PEDro scale
Fair methodological quality5−0.18−0.400.046.6124%
Good methodological quality16−0.37−0.49−0.2422.2833%

Abbreviatures: ACT: Acceptance and Commitment therapy; CBT: Cognitive-behavioral therapy; CI: Confidence interval; e-BMT: Telematic behavioral techniques; N/A: Not Applicable; SMD: Standardized mean difference; Y/N: Yes.

3.4.2. Anxiety

According to the influence analyses, we conducted a sensitivity analysis without Trudeau et al. [62]. We found a statistically significant small effect size (21 RCTs; n = 2578; SMD = −0.32; 95% CI −0.42, −0.21) of e-BMT on anxiety compared with usual care or waiting list, with significant heterogeneity (Q = 33.47 (p = 0.04); I2 = 37% (0%, 63%); PI −0.64, 0.00) and a moderate strength of evidence (Figure 3). Since PI crosses zero, we cannot be confident that future studies will not find contradictory results; however, the results appear to be robust to different p-value functions. With respect to the presence of publication bias, the funnel and Doi plots show a symmetrical pattern, demonstrating no asymmetry (LFK index = −0.48). Statistical analyses are detailed in Appendix A.8. Subgroup analyses are detailed in Table 1b.
Figure 3

Sensitivity analysis of the anxiety variable for telematic behavioral modification techniques against usual care or waiting list. Negative results favor the intervention group. The small boxes with the squares represent the point estimate of the effect size and sample size. The lines on either side of the box represent a 95% confidence interval (CI). e-BMT: Telematic Behavioral Modification Techniques.

3.4.3. Stress

We found no statistically significant effect size (4 RCTs; n = 789; SMD = −0.13; 95% CI −0.28, 0.02) of e-BMT on stress compared with usual care or waiting list, with significant heterogeneity (Q = 1.33 (p = 0.72); I2 = 0% (0%, 85%); PI −0.34, 0.07) and a moderate strength of evidence (Figure 4). Since PI crosses zero, we cannot be confident that future studies will not find contradictory results. With respect to the presence of publication bias, the funnel and Doi plots show an asymmetrical pattern, demonstrating minor asymmetry (LFK index = −1.55). When the sensitivity analysis is adjusted for publication bias, there is no influence on the estimated effect. Statistical analyses are detailed in Appendix A.9.
Figure 4

Statistical analysis of the stress variable for telematic behavioral modification techniques against usual care or waiting list. Negative results favor intervention group. The small boxes with the squares represent the point estimate of the effect size and sample size. The lines on either side of the box represent a 95% confidence interval (CI). e-BMT: Telematic Behavioral Modification Techniques.

GRADE’s overall strength of the evidence is detailed in Table 2.
Table 2

GRADE’s overall strength of the evidence.

Certainty Assessment No. of ParticipantsEffectCertainty
Outcome (No. of Studies)Study DesignRisk of BiasInconsistencyIndirectnessImprecisionPublication Biase-BMTControlAbsolute(95% CI)
Depressive symptoms (n = 32)RCTSeriousSeriousNot seriousNot seriousNot serious18431688−0.35(−0.46; −0.24) Low ⊕⊕
Anxiety (n = 21)RCTSeriousNot SeriousNot seriousNot seriousNot serious14121166−0.32(−0.42; −0.21) Moderate ⊕⊕⊕
Stress (n = 4)RCTSeriousNot seriousNot seriousNot seriousNot serious399390−0.13(−0.28; 0.02) Moderate ⊕⊕⊕

CI: Confidence interval, e-BMT: Telematic Behavioral Modification Techniques, RCT: Randomized controlled trial.

4. Discussion

The primary aim of this systematic review with meta-analysis was to evaluate the effectiveness of e-BMT compared with usual care/waiting list or in-person BMT in terms of psychological variables. Secondly, we aimed to sub-analyze the results by intervention parameters and diagnostic conditions. The main results found that e-BMT seems to be an effective option for the management of anxiety and depressive symptoms in patients with musculoskeletal conditions causing chronic pain but not to improve stress symptoms. e-BMT does not seem to provide greater improvement than in-person BMT for psychological variables. Several research studies have been published and have shown similar results to those found in this review with meta-analysis with regard to depressive and anxiety symptoms. For example, the rapid review conducted by Varker et al. [83] aimed to evaluate the effectiveness of e-BMT (by videoconference) and also through conventional mobile phone calls for people with high levels of anxiety and depression. The main results showed that both rehabilitation modalities produced significant positive results in terms of decreasing the levels of both psychological variables. In addition to this, the review conducted by McCall et al. [84] found that delivering psychological telematic interventions resulted in a significant decrease in depressive symptoms but could not be proven to be effective in comparison to face-to-face psychological intervention. Anxiety symptoms could not be assessed. This work included few studies, so the results have to be interpreted with caution. In addition to being a possible alternative to in-person treatment, e-BMT appears to be a cost-effective technique compared to in-person BMT. De Boer et al. compared e-BMT and in-person BMT in patients with chronic pain and found that the costs of online CBT were EUR 199 lower than in-person BMT [85]. Similarly, Aspvall et al. found that after 6 months of follow-up in children and adolescents with obsessive compulsive disorder, there was a difference of USD 1688 in favor of e-BMT [86]. Healthcare systems and guidelines should seriously consider implementing e-BMT in the management of patients with musculoskeletal disorders causing chronic pain.

4.1. Practical Implication

Concerning clinical implications, the results showed good results in favor of e-BMT. This gives us an effective treatment window in the COVID-19 era, so we are going to have a greater impact on patients with persistent pain. In addition, there is a decentralization of interventions, which may have some positive effects such as improving and increasing adherence to treatments due to easier accessibility, as well as lowering barriers to access or facilitating follow-up. Future studies should also focus on longer follow-ups to see this effectiveness and evaluate variables such as motivation or adherence to chronic pain treatments. Finally, telemedicine rehabilitation may lead to lower costs for both patients and therapists, which may reduce waiting lists for clinical treatments.

4.2. Limitations

We found limited evidence for depressive symptoms; true effects might be different from our estimated effects. We found the presence of publication bias for depressive and stress symptoms; however, adjustments did not influence the results. All the studies have a high risk of bias; results should be interpreted cautiously. Future studies should improve their design quality to enhance our trust in their results. We have pooled together different BMT and conditions. However, we also provided sub-analyses where depressive symptoms and anxiety are analyzed by treatment and by condition.

5. Conclusions

e-BMT is an effective option for the management of anxiety and depressive symptoms in patients with musculoskeletal conditions causing chronic pain and should be introduced when in-person intervention is not possible. However, it does not seem effective to improve stress symptoms.
Table A1

Details of the Studies Included in the Systematic Review.

Authors, YearDesignCountryParticipantsSample Size (n)Age (Mean (SD))GenderConditionInterventionModalityFormatComparatorOutcomesResults
Amorim et al., 2019 Pilot RCT Australia N = 6858.3 (13.4) yrs50%F/50%MChronic LBPActivity tracker and monitoring application.+ Telephone follow-upMobile applicationAdvice to stay active and booklet Depressive symptoms, anxiety and stress: DASS No significant differences on the outcomes.
Ang et al., 2010 RCT USA N = 3248.9 (10.9) yrs100%FFibromyalgiaCBT+ Usual careTelephoneUsual care Depressive symptoms: PHQ-8 Non-significant difference on depressive symptoms (p = 0.8).
Berman et al., 2009 RCT USA N = 8965.8 (N/R) yrs87%F/13%MUnspecified chronic painSelf-care interventionInternet-basedNo intervention Depressive symptoms: CES-D 10 Small non-significant effect on anxiety and depressive symptoms only in self-care group (p > 0.05).
Boselie et al., 2018 RCT The Netherlands N = 33N/R yrsN/R%F/N/R%MUnspecified chronic painPositive psychologyInternet-basedWaiting list Depressive symptoms and anxiety: HADS Significant main effect of PPI condition on anxiety (p = 0.02) and depressive symptoms (p = 0.01).
Bossen et al., 2013 RCT The Netherlands N = 19962.0 (5.7) yrs65%F/35%MKnee and hip OABehavior-graded activity programInternet-basedWaiting list Anxiety and depressive symptoms: HADS At the end of the intervention, intervention group showed less anxiety (p = 0.007). Other outcomes showed no significant differences.
Brattberg, 2007 RCT Sweden N = 6047.0 (8.0) yrs90%F/10%MUnspecified chronic painSupport/self-help group about pain. Internet-based videos or CDsWaiting list Anxiety and Depressive symptoms: HADS Intervention group showed a higher improvement in depressive symptoms over time (p = 0.04) but not in anxiety (p = 0.4).
Brattberg, 2008 RCT Sweden N = 6643.8 (8.8) yrs100%FFibromyalgiaEmotional freedom techniquesInternet-basedWaiting list Anxiety and Depressive symptoms: HADS Intervention group showed a statistically significant time*group interaction in depressive symptoms (p = 0.02) and anxiety (p = 0.03).
Bromberg et al., 2012 RCT USA N = 18942.6 (11.5) yrs89%F/11%MChronic migraineStructured behavior changes program+Usual careInternet-basedUsual care Depressive symptoms, anxiety and stress: DASS-21 Intervention group showed a higher improvement in depressive symptoms (p = 0.008) and stress (p = 0.04), but not on anxiety.
Buhrman et al., 2004 RCT Sweden n = 5644.6 (10.4) yrs63%F/37%MChronic back painOnline CBT + Relaxation with CDs + Telephone calls about goalsInternet-basedWaiting list Anxiety and depressive symptoms: HADS There was no significant main effects difference on anxiety and depressive symptoms.
Buhrman et al., 2011 RCT Sweden N = 5443.2 (9.8) yrs69%F/32%MChronic back painOnline CBTInternet-basedWaiting list Anxiety and depressive symptoms: HADS There were no significant differences between group for anxiety and depressive symptoms.
Dear et al., 2013 RCT Australia N = 6349.0 (13) yrs85%F/15%MUnspecified chronic painOnline CBTInternet-basedWaiting list -Depressive symptoms: PHQ-9 -Anxiety: GAD-7 Intervention had a significantly higher post-treatment improvement in depressive symptoms (p < 0.001), anxiety (p < 0.001).
Dear et al., 2015 RCT Australia N = 49050 (13) yrs80%F/20%MUnspecified chronic painG1: Online CBT + Regular online contactG2: Online CBT + optimal online contactG3: Online CBTInternet-basedWaiting list -Depressive symptoms: PHQ-9 -Anxiety: GAD-7 Intervention groups had significantly lower scores than waiting list for depressive symptoms and anxiety (p < 0.001) post-treatment.
Devineni and Blanchard, 2005 RCT USA N = 8642.2 (11.9) yrs62%F/38%MChronic migraine and/or tension-type headacheBehavioral headache-related interventionInternet-basedWaiting list Depressive symptoms: CES-D There was no statistically significant difference for depressive symptoms (p = 0.11) and anxiety (p = 0.20).
Ferwerda et al.,2017 RCT The Netherlands N = 13356.4(10) yrs64%F/36%MRheumatoid arthritisCBTInternet-basedUsual care -Depressive symptoms: BDI -Negative mood and Anxiety: IRGL Intervention group report a larger decrease in anxiety (p < 0.001) and depressed mood (p < 0.001) than control group.
Friesen et al., 2017 RCT Canada N = 6048.0 (11.0) yrs95%F/5%MFibromyalgiaCBT + Telephone callsInternet-basedWaiting list -Anxiety: GAD-7 -Depressive symptoms: PHQ-9 -Anxiety and depressive symptoms: HADS Intervention group had a significantly higher improvement in anxiety (p = 0.030) and depressive symptoms (p < 0.001). There were also statistically significant time by group interactions for HADS-depressive symptoms (p = 0.007), and HADS-anxiety (p = 0.001).
Heapy et al., 2017 RCT USA N = 12557.9 (11.6) yrs22%F/78%MChronic back painCBTInteractive voice responseFace-to-Face CBT Depressive symptoms: BDI-II There were no significant differences between e-CBT and face-to-face CBT in depressive symptoms.
Hedman-Lagerlöf et al., 2018 RCT Sweden N = 14050.8 (24--77) yrs98%F/2%MFibromyalgiaOnline exposure therapyInternet-basedWaiting list -Depressive symptoms: PHQ-9 -Anxiety: GAD-7 There were statistically significant interactions in favor of intervention group for depressive symptoms and anxiety (all, p < 0.001).
Herbert et al., 2017 RCT USA N = 12818%F/82%M52.0 (13.3) yrsUnspecific chronic painACTVideo teleconferencingFace-to-face ACT -Depressive symptoms: PHQ-9 -Pain-related anxiety: PASS-20 There were no significant differences for any outcomes.
Hernando-Garijo et al., 2021 RCT Spain N = 3453.4 (8.8) yrs100%FFibromyalgiaVideo-guided aerobic training + usual medical prescriptionVideoconferencingUsual medical prescription Anxiety and depressive symptoms: HADS There was a statistically significant higher improvement in psychological distress (p = 0.002) according to HADS than control group.
Juhlin et al., 2021 RCT Sweden N = 13947.6 (10.1) yrs90%F/10%MChronic widespread painPerson-centered intervention supported by online platformInternet-basedPerson-centered intervention Stress: SCI-93 No statistically significant differences between groups for stress (p = 0.21).
Lin et al., 2017 RCT Germany N = 20151.0 (12.4) yrs86%F/14%MUnspecific chronic painOnline guided ACTInternet-basedWaiting list Depressive symptoms: PHQ-9 Anxiety: GAD-7 There was a significant interaction effect for group x time on depressive symptoms (p < 0.05) in favor of intervention group.
Moessner et al., 2012 RCT Germany N = 7545.9 (9.1) yrs56%F/44%MChronic back painSelf-monitoring + Online guided chat Internet-basedUsual care Anxiety and depressive symptoms: HADS There were no significant differences in other outcomes.
Peters et al., 2017 RCT Sweden N = 28448.6 (12.0) yrs85%F/15%MChronic back, neck or shoulder painG1: Online Positive psychologyG2: Online CBTInternet-basedWaiting list Depressive symptoms and Anxiety: HADS Both intervention groups showed significant differences with the waiting list group for depressive symptoms (p < 0.001). There were also significant differences for anxiety.
Petrozzi et al., 2019 RCT New Zealand N = 10850.4 (13.6) yrs50%F/50%MChronic LBPOnline CBT+Usual careInternet-basedUsual care Depressive symptoms, anxiety and stress: DASS-21 There were no statistically significant differences between the two groups for depressive symptoms (0.98), anxiety (p = 0.19) or stress (p = 0.41) at any time-points.
Rickardsson et al., 2021 RCT Sweden N = 11349.5 (12.1) yrs75%F/25%MUnspecific chronic painOnline ACTInternet-basedWaiting list Anxiety: GAD-7 Depressive symptoms: PHQ-9 The intervention group showed significant interaction effects of time x group for anxiety (p = 0.03) and depressive symptoms (p = 0.001).
Ruehlman et al., 2012 RCT USA N = 30544.9 (N/R) yrs64%F/36%MUnspecific chronic pain Online self-managementInternet-basedUsual care -Depressive symptoms: CES-D -Depressive symptoms, anxiety and stress: DASS Intervention group showed a significant group x time interaction in depressive symptoms (p = 0.03 and p = 0.04), stress (p = 0.00) and anxiety (p = 0.05)
Sander et al., 2020 N = 29552.8 (7.7) yrs62%F/38%MUnspecific chronic painOnline CBT + Usual careInternet-basedUsual Care Depressive symptoms: HamD, QIDS score and PHQ-9 Intervention group had a statistically significant greater improvement of all the outcomes compared with control group.
Schlickler et al., 2020 RCT Germany N = 7650.8 (7.9) yrs55%F/45%MChronic back painOnline CBT-based interventionInternet-based and mobile-basedWaiting list -Depressive symptoms: CES-D and QIDS-SR16 -Anxiety: HamADS There was a significant reduction in both treatment in depressive symptoms according to CES-D (p < 0.001) with a significant difference in favor of the intervention group post-treatment (p = 0.03). Intervention group also showed a significant greater reduction in anxiety (p = 0.001).
Scott et al., 2018 RCT UK N = 6345.5 (14.0) yrs64%F/36%MUnspecific chronic painOnline ACT + Usual careInternet-basedUsual care Depressive symptoms: PHQ-9 Intervention group showed medium effects on depressive symptoms.
Shigaki et al., 2013 RCT USA N = 10849.8 (11.9) yrs94%F/6%MRheumatoid arthritisEducation and social network website about Rheumatoid arthritis + Telephone callsInternet-basedWaiting list Depressive symptoms: CES-D No statistically significant differences in depressive symptoms (p = 0.14).
Simister al., 2018 RCT N = 6739.7 (9.4) yrs95%F/5%MFibromyalgiaOnline ACT + Usual careInternet-basedUsual care Depressive symptoms: CES-D Intervention group significantly improved, relative to control group, on depressive symptoms (p = 0.02).
Smith et al., 2019 RCT Australia N = 8045.0 (13.9) yrs88%F/12%MUnspecific chronic painOnline self-management and CBT-based interventionInternet-basedUsual care Depressive symptoms: PHQ-9 There was no statistically significant interaction for depressive symptoms.
Ström et al., 2000 RCT Sweden N = 4536.7 (N/R) yrs69%F/31%MRecurrent headache sufferersOnline relaxation and problem-solving interventionInternet-basedWait-list Depressive symptoms: BDI There were no significant differences for depressive symptoms.
Tavallaei et al., 2018 RCT Iran N = 3033.7 (9.0) yrs100%FMigraine and tension-type headacheMindfulness-based Stress Reduction BibliotherapyInternet-basedUsual care Depressive symptoms, anxiety and stress: DASS-21 N/R
Trompetter et al., 2015 RCT The Netherlands N = 23852.7 (12.4) yrs76%F/24%MUnspecific chronic painOnline ACTInternet-basedWaiting list Depressive symptoms and Anxiety: HADS There was a statistically significant difference in depressive symptoms (p = 0.006).
Trudeau et al., 2015 RCT USA N = 22849.9 (11.6)68%F/32%MArthritisOnline self-management interventionInternet-basedWaiting List Depressive symptoms, anxiety, and stress: DASS-21 No statistically significant condition-by-time effect on the three subscales of the DASS-21.
Vallejo et al., 2015 RCT Spain N = 6051.6 (9.9) yrs100%FFibromyalgiaOnline CBT + Usual careInternet-basedG1: Face-to-face CBT + Usual careG2: Usual care Depressive symptoms and anxiety: HADS Depressive symptoms: BDI Both groups improved depressive symptoms (both, p < 0.01) and HADS scores.
Westenberg et al., 2018 RCT USA N = 12654.5 (15.0) yrs50%F/50%MUpper limb disordersOnline MindfulnessInternet-basedAttention control -Depressive symptoms: N/R -Anxiety: N/R Intervention group had statistically significant improvements in depressive symptoms (p = 0.004) and anxiety (p = 0.024).
Williams et al., 2010 RCT USA N = 11850.5 (11.5) yrs95%F/5%MFibromyalgiaOnline CBT + Usual careInternet-basedUsual care -Depressive symptoms: CES-D -Anxious mood: STPI—state anxiety There were no statistically significant differences in anxiety and depressive symptoms.
Wilson et al., 2015 RCT USA N = 11449.3 (11.6) yrs78%F/12%MUnspecific chronic painOnline pain management programInternet-basedWaiting list Depressive symptoms: PHQ-9 There were no statistically significant interactions for group-by-time on depressive symptoms.
Wilson et al., 2018 RCT USA N = 6044.3 (12.0) yrs44%F/56%MUnspecific chronic painOnline self-management programInternet-basedWaiting list Depressive symptoms: PHQ-8 Intervention group had higher depressive symptoms score at the end of the intervention (p = 0.001).

Abbreviatures: %F: Proportion of women; %M: Proportion of men; ACT: Acceptance and Commitment therapy; BDI: Beck Depression Inventory; BDI-II: Beck Depression Inventory-II, CBT: Cognitive-behavioral therapy; CES-D: Center for Epidemiological Studies Depression Scale; CES-D 10: Center for Epidemiologic Studies Short Depression Scale; DASS: Depression Anxiety Stress Scale; DASS-21: 21-Item Depression Anxiety Stress Scales; GAD-7: 7-Item Generalized Anxiety Disorder; HADS: Hospital Anxiety and Depression Scale; LBP: Low back pain; HamADS: Hamilton Anxiety and Depression Scale; HamD: Hamilton Depression Rating Scale; IRGL: Impact of Rheumatic Diseases on General Health and Lifestyle; N/R: Not reported; PASS-20: 20-item Pain Anxiety Symptoms Scale-Short Form; PHQ-8: 8-Item Personal Health Questionnaire Depression Scale; PHQ-9: 9-Item Personal Health Questionnaire Depression Scale; QIDS: Quick Inventory of Depressive Symptomatology; RCT: Randomized controlled trial; SD: Standard deviation; SCI-93: Stress and Crisis Inventory; STPI: State-Trait Personality Inventory; QIDS-SR16: Quick Inventory of Depressive Symptomatology Self-Report.

Table A2

Details of the Interventions.

Authors, YearInterventionComparator
FormatEquipment and Contact FormModality and ContentDuration and Frequency,Follow-UpFormatEquipmentModality and ContentDuration and Frequency, Follow-Up
Amorim et al., 2019 Mobile applicationWritten, pedometerTelephone call, messagePhysical exercise, activity tracker, lessons

Goal setting (behavior)

Problem solving

Action planning

Social support (emotional)

Instruction on how to perform the behavior

Feedback on outcomes of behavior

Graded tasks

6 months1 face-to-face interview and2 calls/monthFollow-up: N/ARecommendationsWritten, brief advice

Autonomous increase in physical activity

Benefits of physical activity

6 monthsN/AFollow-up: N/A
Ang et al., 2010 Telephone call + usual careWrittenTelephone callCBT. Lessons, relaxation

Action planning

Reduce negative emotions

Framing/reframing

6 weeks1 session/weekFollow-up: 12 weeks Usual care

Usual treatment by the physician

6 weeksN/AFollow-up: 12 weeks
Berman et al., 2009 Internet-basedImages, audioEmailSelf-care. Mind–body exercises and lessons

Problem solving

Action planning

Monitoring of behavior by others without feedback

Instruction on how to perform the behavior

6 weeks≥1 session/weekFollow-up: N/ANo interventionN/AN/AN/AN/AFollow-up: N/A
Boselie et al., 2018 Internet-basedOnline platformTelephone call, emailPositive psychology exercises

Problem solving

Social support (unspecified)

Instruction on how to perform the behavior

8 weeksCall: weeks 1, 3, 5,7Email: weeks 2, 4, 6, 8Follow-up: N/AWaiting listN/AN/AN/AN/AFollow-up: N/A
Bossen et al., 2013 Internet-basedWritten, videoEmailBehavior-graded activity and exercises

Goal setting (behavior)

Instruction on how to perform the behavior

Graded tasks

9 weeks≥1 session/weekFollow-up: 12 weeksWaiting listN/AN/AN/AN/AFollow-up: 12 weeks
Brattberg, 2007 Internet-basedWritten, videoInternet guided chatSelf-help about pain.

Problem solving

Monitoring of emotional consequences

Anticipated regret

Reduce negative emotions

20 weeks1 video/weekFollow-up: 12 months Waiting list Maintain pharmacotherapy20 weeksN/AFollow-up: 12 months
Brattberg, 2008 Internet-basedWrittenTelephone call, emailSelf-management. Emotional Freedom TechniquesSelf-monitoring of outcome of behavior8 weeks1 time/dayFollow-up: N/A Waiting list N/AN/AN/AFollow-up: N/A
Bromberg et al., 2012 Internet-based +usual careWrittenEmailBehavior change, physical activity, lessons

Goal setting (outcome)

Monitoring of behavior by others without feedback

Self-monitoring of behavior

Graded tasks

6 months≥2 sessions/week (first 4 weeks)≥1 sessions/month (final 5 month)Follow-up: N/AUsual careN/AMaintain the routine care and self-management effortN/AN/AFollow-up: N/A
Buhrman et al., 2004 Internet-basedSlideshow, audioTelephone callCBT. Physical and psychological exercises, relaxation

Goal setting (behavior)

Problem solving

Instruction on how to perform the behavior

Self-monitoring of behavior

Graded tasks

6 weeks1 call/weekFollow-up: 3 monthsWaiting listN/AN/AN/AN/AFollow-up: 3 months
Buhrman et al., 2011 Internet-basedWrittenEmailCBT. Physical exercise, relaxation, cognitive skills

Self-monitoring of behavior

8 weeksN/RFollow-up: 12 weeksWaiting listN/AN/AN/AN/AFollow-up: 12 weeks
Dear et al., 2013 Internet-basedWrittenTelephone callCBT. Lessons, homework

Goal setting (behavior)

Graded tasks

8 weeks1 lesson/7–10 days1 call/weekFollow-up: 3 monthsWaiting listN/AN/AN/AN/AFollow-up: 3 months
Dear et al., 2015 Internet-based

G1: CBT + Regular online contact

G2: CBT + optimal online contact

G3: CBT

SlideshowTelephone call, email
CBT.Lessons, homework

Problem solving

Instruction on how to perform the behavior

Behavioral practice

Graded tasks

8 weeks1 lesson/7–10 daysG1: 1 call/weekG2: as-needed callsG3: no contactFollow-up: 3 monthsWaiting listN/AN/AN/AN/AFollow-up: 3 months
Devineni and Blanchard, 2005 Internet-basedWritten, audio, web pagesEmailLessons, exercises, relaxation,Behavioral headache-related interventionAutogenic training

Self-monitoring of outcome

Reduce negative emotions

4 weeksN/RFollow-up: 2 months Waiting list N/AN/AN/AFollow-up: 2 months
Ferwerda et al., 2017 Internet-basedWrittenEmailCBT. Lessons, homework

Goal setting (behavior)

Problem solving

Action planning

Instruction on how to perform the behavior

Reduce negative emotions

Distraction

Framing/reframing

17 to 32 weeks1 email/1–2 weeksFollow-up: 12 monthsUsual careN/RRheumatological careN/RN/RFollow-up: 12 months
Friesen et al., 2017 Internet-basedSlideshowTelephone call, emailCBT. Lessons, homework

Problem solving

Feedback on perform the behavior

Instruction on how to perform the behavior

8 weeks1 email and call/weekFollow-up: N/AWaiting listN/AN/AN/AN/AFollow up: N/A
Heapy et al., 2017 Interactive voice responseWritten, images, audio, pedometerTelephone callCTB. Lessons, relaxation

Goal setting (outcome)

Feedback on behavior

Graded tasks

Reduce negative emotions

10 weeks1 call/dayFollow-up: 9 monthsFace-to-faceWritten, images, audio, pedometerCBT. Lessons, relaxation

Goal setting (outcome)

Feedback on behavior

Graded tasks

Reduce negative emotions

10 weeks1 session/weekFollow-up: 9 months
Hedman-Lagerlöf et al., 2018 Internet-basedWrittenTelephone call, messageLessons, homework, mindfulness

Goal setting (behavior)

Problem solving

Monitoring of behavior by others without feedback

Exposure

Graded tasks

10 weeks1–3 contact/weekFollow-up: 12 monthsWaiting listN/AN/AN/AN/AFollow-up: 12 months
Herbert et al., 2017 VideoconferencingWrittenN/RACT. Mindfulness, lessons

Goal setting

Information about emotional consequences

8 weeks1 session/weekFollow-up: 6 monthsFace-to-faceWrittenACT. Mindfulness, lessons

Goal setting

Information about emotional consequences

8 weeks1 session/weekFollow-up: 6 months
Hernando-Garijo et al., 2021 Videoconferencing + usual careVideoVideo callAerobic exercise

Low-impact exercise

15 weeks2 session/weekFollow-up: N/AUsual careN/A

Maintain pharmacotherapy

15 weeksN/AFollow-up: NA
Juhlin et al., 2021 Internet-basedDigital platformMessagePerson-centered intervention. Physical and psychological exercises

Goal setting (behavior)

Problem solving

Action planning

6 months1 contact/weekFollow-up: N/AFace-to-face(1 session)N/A

Person-centered intervention. Physical and psychological exercises

6 monthsN/AFollow-up: N/A
Lin et al., 2017 Internet-basedWritten, audio, videoEmail, messageACT. Lessons, mindfulness

Goal setting (behavior)

Reduce negative emotions

9 weeks1 session/weekFollow-up: 6 monthsWaiting listN/A

N/A

N/AN/AFollow-up: 6 months
Moessner et al., 2012 Internet-basedN/RInternet guided chatSelf-monitoring. Lessons

Self-monitoring of behavior

Behavioral practice/rehearsal

12–15 weeks1 session/weekFollow-up: 6 monthsUsual careN/AN/R12–15 weeks1 session/weekFollow-up: 6 months
Peters et al., 2017 Internet-basedWrittenTelephone call, emailG1: Positive psychology. Psychological exercises

Goal setting (behavior)

Graded tasks

Reduce negative emotions

G2: CBT. Lessons, homework, relaxation

Problem solving

Action planning

Social support (unspecified)

Framing/reframing

8 weeks1 lesson/weekCall: weeks 1, 3, 5, 7Email: weeks: 2, 4, 6, 8Follow-up: 6 monthsWaiting listN/AN/AN/AN/AFollow-up: 6 months
Petrozzi et al., 2019 Internet-based + usual careWrittenTelephone callCBT. Lessons, homework

Problem solving

Self-monitoring behavior

Instruction on how to perform the behavior

Distraction

8 weeks1 lesson/week1 call/weekFollow-up: 12 monthsUsual careN/A

Physical treatment (manual therapy, exercise and/or education)

Recommendation for physical activity

8 weeks12 sessions (variable frequency)Follow-up: 12 months
Rickardsson et al., 2021 Internet-basedWritten, image, audioTelephone call, messageACT. Lessons

Instruction on how to perform the behavior

Feedback on behavior

Graded tasks

Non-specific reward

Distraction

8 weeks7 sessions/week≥2 messages/weekFollow-up: 12 monthsWaiting listN/A

Maintain usual treatment

N/AN/AFollow-up: 12 months
Ruehlman et al., 2012 Internet-basedWritten, imageEmail, messageSelf-management + e-community. Physical exercise, lessons, homework, relaxation

Goal setting (outcome)

Action planning

Self-monitoring of outcome of behavior

Instruction on how to perform the behavior

Reduce negative emotions

6 weeksN/RFollow-up: 14 weeksUsual careN/AN/R6 weeksN/AFollow-up: 14 weeks
Sander et al., 2020 Internet-based + usual careWritten, audio, videoTelephone call, email, messageCBT. Lessons, homework, relaxation

Problem solving

Action planning

Feedback on behavior

Reduce negative emotions

9 weeks7 sessions/weekFollow-up:12 monthsUsual careN/AMedical or psychological treatment9 weeksN/RFollow-up:12 months
Schlickler et al., 2020 Internet-based + mobile-basedN/REmail, messageCBT. Lessons, mindfulness, relaxation

Problem solving

Feedback on behavior

Social support

Non-specific reward

Reduce negative emotions

Framing/reframing

9 weeks7 lessons/weekFollow-up: 6 monthsWaiting listN/AN/AN/AN/AFollow-up: 6 months
Scott et al., 2018 Internet-based + usual careVideoTelephone call, emailACT. Lessons

Goal setting (behavior)

Feedback on behavior

Instruction on how to perform the behavior

Monitoring of emotional consequences

5 weeks2 lesson/week (first 3 weeks), 1 lesson/week (final 2 weeks)Follow-up: 9 monthsUsual careN/A

Medical treatment

Instruction on how to perform the behavior

5 weeksN/AFollow-up: 9 months
Shigaki et al., 2013 Internet-basedSlideshowTelephone call, message, online chatLessons, homework

Problem solving

Self-monitoring behavior

10 weeks1 lesson/week1 call/weekFollow-up: N/A Waiting list

N/A

N/AN/AFollow-up: N/A
Simister al., 2018 Internet-based + usual careWritten, audio, videoEmailACT. Lessons, homeworkFeedback on behaviorNon-specific reward8 weeksN/RFollow-up: 3 monthsUsual careN/A

Maintain usual treatment

8 weeksN/AFollow-up: 3 months
Smith et al., 2019 Internet-basedWritten, image, audio, videoTelephone call, emailCBT and self-management. Multidisciplinary program with physical exercise, lessons, homework, relaxation

Goal setting (behavior and outcome)

Problem solving

Instruction on how to perform the behavior

Graded tasks

Multidisciplinary program

Physical therapy, psychologist

4 months2 lessons/monthFollow-up: 7 monthsUsual careN/A

Maintain usual treatment

4 monthsN/AFollow-up: 7 months
Ström et al., 2000 Internet-basedWrittenEmailLessons, relaxation

Problem solving

Instruction on how to perform the behavior

Feedback on outcome of behavior

6 weeks1 lesson/weekFollow-up: N/AWaiting listN/AN/AN/AN/AFollow-up: N/A
Tavallaei et al., 2018 Internet-basedWrittenN/RMindfulness-based stress reduction bibliotherapy

Problem solving

Action planning

Distraction

8 weeks1 lesson/weekFollow-up: N/AUsual careN/A

Pharmacotherapy

8 weeksN/AFollow-up: N/A
Trompetter et al., 2015 Internet-basedWrittenEmailACT. Lessons, mindfulness

Self-monitoring of behavior

Non-specific reward

Distraction

3 months≥3 h/weekFollow-up: 6 monthsWaiting listN/AN/AN/AN/AFollow-up: 6 months
Trudeau et al., 2015 Internet-basedMultimedia materialsTelephone call, emailSelf-management. Lessons

Problem solving

Instruction on how to perform the behavior

Reduce negative emotions

6 months≥2 sessions/week (1 month)1 session/month (5 months)Follow-up: N/AWaiting listN/AN/AN/AN/AFollow-up: N/A
Vallejo et al., 2015 Internet-based + usual careWritten, images, audioMessageCBT. Lessons, homework, relaxation

Problem solving

Feedback on behavior

Reduce negative emotions

Framing/reframing

10 weeks1 session/weekFollow-up: 12 monthsG1: Face-to-face + usual careWritten, images, audioG2: Usual careN/AG1: CBT. Lessons, homework, relaxation

Problem solving

Reduce negative emotions

Framing/reframing

G2: Pharmacotherapy
10 weeksG1: 1 session/weekG2: N/AFollow-up (only G1): 12 months
Westenberg et al., 2018 Internet-basedWritten, videoN/RMindfulness

Reduce negative emotions

60-s videoN/RFollow-up: N/AAttention controlWritten

Health information

60-s readN/RFollow-up: N/A
Williams et al., 2010 Internet-based + usual careWritten, audio, videoNo contactSelf-management. Lessons, homework, relaxation

Goal setting (behavior)

Problem solving

Self-monitoring of behavior

Social support (unspecified)

Instruction on how to perform the behavior

Graded tasks

Framing/reframing

6 monthsN/RFollow-up: N/A Usual care

Maintain usual treatment from care physician

6 monthsN/AFollow-up: N/A
Wilson et al., 2015 Internet-basedN/R N/RSelf-management. Lessons, exercises, relaxation

Goal setting (outcome)

Self-monitoring or outcome of behavior

8 weeksN/RFollow-up: N/AUsual careN/AN/A8 weeksN/RFollow-up: N/A
Wilson et al., 2018 Internet-basedWrittenInteractive activitySelf-management. Lessons, homework

Self-monitoring of behavior

Behavioral practice/rehearsal

8 weeksN/RFollow-up: N/AWaiting listWritten

Educational tips

8 weeks1 email/weekFollow-up: N/A

ACT: Acceptance and Commitment therapy; CBT: Cognitive-behavioral therapy; N/A: Not applicable; N/R: Not reported; NSAIDs: Nonsteroidal anti-inflammatory drugs.

Table A3

PEDro scale.

Items
Articles1234567891011Total
Amorim et al., 2019 11110010111 7
Ang et al., 2010 11010011011 6
Berman et al., 2009 11010001011 5
Boselie et al., 2018 01010000011 4
Bossen et al., 2013 11110000111 6
Brattberg, 2007 11110001111 7
Brattberg, 2008 11110001111 7
Bromberg et al., 2012 11010001111 6
Buhrman et al., 2004 11010001011 5
Buhrman et al., 2011 11110001111 7
Dear et al., 2013 11010001011 5
Dear et al., 2015 11110001011 6
Devineni and Blanchard, 2005 11110001011 6
Ferwerda et al., 2017 11110001111 7
Friesen et al., 2017 11110001011 6
Heapy et al., 2017 11110000111 6
Hedman-Lagerlöf et al., 2018 11110001011 6
Herbert et al., 2017 11010011111 7
Hernando-Garijo et al., 2021 11010011111 7
Juhlin et al., 2021 11110000111 6
Lin et al., 2017 11110000111 6
Moessner et al., 2012 11010000111 5
Peters et al., 2017 11010000111 5
Petrozzi et al., 2019 11110001111 7
Rickardsson et al., 2020 11110001111 7
Ruehlman et al., 2012 11010000111 5
Sander et al., 2020 11110010111 7
Schlicker et al., 2021 11010001111 6
Scott et al., 2018 11110001111 7
Shigaki et al., 2013 11000001011 4
Simister et al., 2018 11110001111 7
Smith et al., 2019 11010010111 6
Ström et al., 2000 11010000111 5
Tavallaei et al., 2018 11000001011 4
Trompetter et al., 2014 11010001111 6
Trudeau et al., 2015 11110001111 7
Vallejo et al., 2015 11010001111 6
Westenberg et al., 2018 11011001111 7
Williams et al., 2010 11110001111 7
Wilson et al., 2015 11010000111 5
Wilson et al., 2018 11011001111 7

Notes: 1: subject choice criteria are specified; 2: random assignment of subjects to groups; 3: hidden assignment; 4: groups were similar at baseline; 5: all subjects were blinded; 6: all therapists were blinded; 7: all evaluators were blinded; 8: measures of at least one of the key outcomes were obtained from more than 85% of baseline subjects; 9: intention-to-treat analysis was performed; 10: results from statistical comparisons between groups were reported for at least one key outcome; 11: the study provides point and variability measures for at least one key outcome.

  78 in total

1.  An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-06       Impact factor: 2.571

2.  RoB 2: a revised tool for assessing risk of bias in randomised trials.

Authors:  Jonathan A C Sterne; Jelena Savović; Matthew J Page; Roy G Elbers; Natalie S Blencowe; Isabelle Boutron; Christopher J Cates; Hung-Yuan Cheng; Mark S Corbett; Sandra M Eldridge; Jonathan R Emberson; Miguel A Hernán; Sally Hopewell; Asbjørn Hróbjartsson; Daniela R Junqueira; Peter Jüni; Jamie J Kirkham; Toby Lasserson; Tianjing Li; Alexandra McAleenan; Barnaby C Reeves; Sasha Shepperd; Ian Shrier; Lesley A Stewart; Kate Tilling; Ian R White; Penny F Whiting; Julian P T Higgins
Journal:  BMJ       Date:  2019-08-28

Review 3.  Self-management program for chronic low back pain: A systematic review and meta-analysis.

Authors:  Shizheng Du; Lingli Hu; Jianshu Dong; Guihua Xu; Xuan Chen; Shengji Jin; Heng Zhang; Haiyan Yin
Journal:  Patient Educ Couns       Date:  2016-07-25

4.  A new improved graphical and quantitative method for detecting bias in meta-analysis.

Authors:  Luis Furuya-Kanamori; Jan J Barendregt; Suhail A R Doi
Journal:  Int J Evid Based Healthc       Date:  2018-12

5.  Guided internet-based cognitive behavioural treatment for chronic back pain reduces pain catastrophizing: a randomized controlled trial.

Authors:  Monica Buhrman; Elisabeth Nilsson-Ihrfeldt; Maria Jannert; Lars Ström; Gerhard Andersson
Journal:  J Rehabil Med       Date:  2011-05       Impact factor: 2.912

6.  Evaluation of How Depression and Anxiety Mediate the Relationship Between Pain Catastrophizing and Prescription Opioid Misuse in a Chronic Pain Population.

Authors:  Javier Arteta; Briana Cobos; Yueqin Hu; Krista Jordan; Krista Howard
Journal:  Pain Med       Date:  2016-02       Impact factor: 3.750

7.  Randomized Controlled Trial of Online Acceptance and Commitment Therapy for Fibromyalgia.

Authors:  Heather D Simister; Gregg A Tkachuk; Barbara L Shay; Norah Vincent; Joseph J Pear; Ryan Q Skrabek
Journal:  J Pain       Date:  2018-03-02       Impact factor: 5.820

8.  RAHelp: an online intervention for individuals with rheumatoid arthritis.

Authors:  Cheryl L Shigaki; Karen L Smarr; Chokkalingam Siva; Bin Ge; Dale Musser; Rebecca Johnson
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-10       Impact factor: 4.794

9.  Happy Despite Pain: A Randomized Controlled Trial of an 8-Week Internet-delivered Positive Psychology Intervention for Enhancing Well-being in Patients With Chronic Pain.

Authors:  Madelon L Peters; Elke Smeets; Marion Feijge; Gerard van Breukelen; Gerhard Andersson; Monica Buhrman; Steven J Linton
Journal:  Clin J Pain       Date:  2017-11       Impact factor: 3.442

10.  Effectiveness of a web-based physical activity intervention in patients with knee and/or hip osteoarthritis: randomized controlled trial.

Authors:  Daniël Bossen; Cindy Veenhof; Karin Ec Van Beek; Peter Mm Spreeuwenberg; Joost Dekker; Dinny H De Bakker
Journal:  J Med Internet Res       Date:  2013-11-22       Impact factor: 5.428

View more
  1 in total

Review 1.  Effect of Exercise on Inflammation in Hemodialysis Patients: A Systematic Review.

Authors:  Erika Meléndez Oliva; Jorge H Villafañe; Jose Luis Alonso Pérez; Alexandra Alonso Sal; Guillermo Molinero Carlier; Andrés Quevedo García; Silvia Turroni; Oliver Martínez-Pozas; Norberto Valcárcel Izquierdo; Eleuterio A Sánchez Romero
Journal:  J Pers Med       Date:  2022-07-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.